New and Revised Vaccine Codes for Early Release

New and Revised Vaccine Codes for Early Release

Influenza is constantly developing new viral strains, which in turn requires the constant development of updated flu vaccines. To keep up, the AMA publishes new and revised vaccine codes twice per year, and when required for emergent/critical distribution.

Two new influenza vaccine codes are available for use Feb. 1, 2015:

  • 90620 Meningococcal recombinant protein and outer membrane vesicle vaccine, Serogroup B, 2 dose schedule, for intramuscular use
  • 90621 Meningococcal recombinant lipoprotein vaccine, Serogroup B, 2 or 3 dose schedule, for intramuscular use

Additionally, the vaccine described by 90630 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use has achieved FDA approval.

Although not an influenza vaccine, 90697 Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenza type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP- IPV-Hib-HepB), for intramuscular use will be active as of Jan. 1, 2015.

An additional 48 vaccine codes in the 90632-90748 range also are revised, effective July 2015. The minor descriptor revisions clarify terminology, but do not change proper code application. Additional format edits are also included for 90647, 90648, 90696, 90702, 90714, and 90721.

A complete listing of all vaccine code changes can be found on the AMA website.

2017-code-book-bundles-728x90-01

John Verhovshek

John Verhovshek

John Verhovshek, MA, CPC, is Managing Editor at AAPC. He has covered medical coding and billing, healthcare policy, and the business of medicine since 1999. He is an alumnus of York College of Pennsylvania and Clemson University, and a member of the Asheville-Hendersonville AAPC Local Chapter.
John Verhovshek

About Has 406 Posts

John Verhovshek, MA, CPC, is Managing Editor at AAPC. He has covered medical coding and billing, healthcare policy, and the business of medicine since 1999. He is an alumnus of York College of Pennsylvania and Clemson University, and a member of the Asheville-Hendersonville AAPC Local Chapter.

5 Responses to “New and Revised Vaccine Codes for Early Release”

  1. Kathleen Arnold says:

    This is very confusing. Meningococcal disease is a bacterial infection and is not related to influenza. CPT codes 90620 and 90621 referenced above are not for influenza vaccines.

  2. MaryAnne Heath says:

    I agree with Kathleen above – I think this is an “oops”. There are no codes 90620 or 90621 in my 2015 CPT, either. :( I do see a new influenza code, 90630, Influenza virus vaccine, quadrivalent (IIV4; split virus, preservative free, for intradermal use.

  3. MaryAnne Heath says:

    …also, I do realize that sometimes CPT codes come into effect after the actual book is published, and this could be where the 90620 and 90621 come into play. But again, they are not for influenza.

  4. Rosa Medrano says:

    Is there anyone that can point me to where I can find the specifications of administration, recommendations for ages and if these vaccines are available for Vaccine for children program?

  5. Linda Caudle says:

    Try looking at the insert that comes with the packaged vaccine

Leave a Reply

Your email address will not be published. Required fields are marked *